Skip to main content
Top
Published in: AIDS Research and Therapy 1/2018

Open Access 01-12-2018 | Research

Multivariate analysis of covariates of adherence among HIV-positive mothers with low viral suppression

Authors: Tamara Nsubuga-Nyombi, Simon Sensalire, Esther Karamagi, Judith Aloyo, John Byabagambi, Mirwais Rahimzai, Linda Kisaakye Nabitaka, Jacqueline Calnan

Published in: AIDS Research and Therapy | Issue 1/2018

Login to get access

Abstract

Background

As part of efforts to improve the prevention of mother-to-child transmission in Northern Uganda, we explored reasons for poor viral suppression among 122 pregnant and lactating women who were in care, received viral load tests, but had not achieved viral suppression and had more than 1000 copies/mL. Understanding the patient factors associated with low viral suppression was of interest to the Ministry of Health to guide the development of tools and interventions to achieve viral suppression for pregnant and lactating women newly initiating on ART as well as those on ART with unsuppressed viral load.

Methods

A facility-based cross-sectional and mixed methods study design was used, with retrospective medical record review. We assessed 122 HIV-positive mothers with known low viral suppression across 31 health facilities in Northern Uganda. Adjusted odds ratios were used to determine the covariates of adherence among HIV positive mothers using logistic regression. A study among health care providers shed further light on predictors of low viral suppression and a history of low early retention. This study was part of a larger national evaluation of the performance of integrated care services for mothers.

Results

Adherence defined as taking antiretroviral medications correctly everyday was low at 67.2%. The covariates of low adherence are: taking other medications in addition to ART, missed appointments in the past 6 months, experienced violence in the past 6 months, and faces obstacles to treatment. Mothers who were experiencing each of these covariates were less likely to adhere to treatment. These covariates were triangulated with perspectives of health providers as covariates of low adherence and included: long distances to health facility, missed appointments, running out of pills, sharing antiretroviral drugs, violence, and social lifestyles such as multiple sexual partners coupled with non-disclosure to partners. Inadequate counseling, stigma, and lack of client identity are the frontline factors accounting for the early loss of mothers from care.

Conclusions

Adherence of 67% was low for reliable viral suppression and accounts for the low viral suppression among HIV-positive mothers studied, in absence of any other factors. This study provided insights into the covariates for low adherence to ART and low viral load suppression; these covariates included taking other medications in addition to ART, missed appointments in the past 6 months, feels like giving up, doesn’t have someone with whom to share private concerns, experienced violence in the past 6 months, and faces obstacles to treatment and confirmed by health providers. To improve adherence, we recommend use of a screening tool to identify mothers with any of these covariates so that more intensive adherence support can be provided to these mothers.
Literature
1.
go back to reference Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment—United States. MMWR Morb Mortal Wkly Rep. 2011;60(47):1618–23. Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment—United States. MMWR Morb Mortal Wkly Rep. 2011;60(47):1618–23.
2.
go back to reference Ng’ambi WF, Tweya H, Speight C, Man-Bourdon C, Hosseinpour M, Phiri S. Determinants of antiretroviral treatment adherence among women accessing PMTCT “Option B+”: a retrospective study at Bwaila Hospital, Malawi. In: IAS conference on HIV pathogenesis, treatment and prevention, 30 June–03 July 2013-Kuala Lumpur, Malaysia. Ng’ambi WF, Tweya H, Speight C, Man-Bourdon C, Hosseinpour M, Phiri S. Determinants of antiretroviral treatment adherence among women accessing PMTCT “Option B+”: a retrospective study at Bwaila Hospital, Malawi. In: IAS conference on HIV pathogenesis, treatment and prevention, 30 June–03 July 2013-Kuala Lumpur, Malaysia.
3.
go back to reference Engell CA, Pham VP, Holzman RS, Aberg JA. Virologic outcome of using tenofovir/emtricitabine to treat hepatitis B in HIV-coinfected patients. ISRN Gastroenterol. 2011; 2011:405390.CrossRefPubMedPubMedCentral Engell CA, Pham VP, Holzman RS, Aberg JA. Virologic outcome of using tenofovir/emtricitabine to treat hepatitis B in HIV-coinfected patients. ISRN Gastroenterol. 2011; 2011:405390.CrossRefPubMedPubMedCentral
4.
go back to reference Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–21.CrossRefPubMed Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–21.CrossRefPubMed
6.
go back to reference Okonji JA. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission. JAIDS J Acquir Immune Defic Syndr. 2012;61(2):249–57.CrossRefPubMed Okonji JA. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission. JAIDS J Acquir Immune Defic Syndr. 2012;61(2):249–57.CrossRefPubMed
7.
go back to reference Simoni JM, Amico KR, Pearson CR, Malow R. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10(6):515–21.CrossRefPubMedPubMedCentral Simoni JM, Amico KR, Pearson CR, Malow R. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10(6):515–21.CrossRefPubMedPubMedCentral
9.
go back to reference Adam BD, Maticka-Tyndale E, Cohen JJ. Adherence practices among people living with HIV. AIDS Care. 2003;15:263–74.CrossRefPubMed Adam BD, Maticka-Tyndale E, Cohen JJ. Adherence practices among people living with HIV. AIDS Care. 2003;15:263–74.CrossRefPubMed
10.
go back to reference Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34:281–8.CrossRefPubMed Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34:281–8.CrossRefPubMed
11.
go back to reference Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19(2):124–33.CrossRefPubMed Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19(2):124–33.CrossRefPubMed
12.
go back to reference Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011;45(3):372–9 (Epub 2011/03/10).CrossRefPubMed Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011;45(3):372–9 (Epub 2011/03/10).CrossRefPubMed
Metadata
Title
Multivariate analysis of covariates of adherence among HIV-positive mothers with low viral suppression
Authors
Tamara Nsubuga-Nyombi
Simon Sensalire
Esther Karamagi
Judith Aloyo
John Byabagambi
Mirwais Rahimzai
Linda Kisaakye Nabitaka
Jacqueline Calnan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2018
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-018-0197-8

Other articles of this Issue 1/2018

AIDS Research and Therapy 1/2018 Go to the issue